Effects of schisandra lignans on the absorption of protopanaxadiol-type ginsenosides mediated by P-glycoprotein and protopanaxatriol-type ginsenosides mediated by CYP3A4
- 17 August 2023
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 318 (Pt B) , 117057
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 44 references indexed in Scilit:
- The protective effects of Schisandra chinensis fruit extract and its lignans against cardiovascular disease: A review of the molecular mechanismsFitoterapia, 2014
- A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseasesJournal of Ginseng Research, 2014
- Pharmacokinetic Compatibility of Ginsenosides and Schisandra Lignans in Shengmai-san: From the Perspective of P-GlycoproteinPLOS ONE, 2014
- In Vivo to In Vitro Effects of Six Bioactive Lignans of Wuzhi Tablet (Schisandra Sphenanthera Extract) on the CYP3A/P-glycoprotein–Mediated Absorption and Metabolism of TacrolimusDrug Metabolism and Disposition, 2014
- In vitro to in vivo evidence of the inhibitor characteristics of Schisandra lignans toward P-glycoproteinPhytomedicine, 2013
- Different pharmacokinetics of the two structurally similar dammarane sapogenins, protopanaxatriol and protopanaxadiol, in ratsFitoterapia, 2013
- Single-pass intestinal perfusion to establish the intestinal permeability of model drugs in mouseInternational Journal of Pharmaceutics, 2012
- Microsomal Cytochrome P450-Mediated Metabolism of Protopanaxatriol Ginsenosides: Metabolite Profile, Reaction Phenotyping, and Structure-Metabolism RelationshipDrug Metabolism and Disposition, 2010
- Schisandrol A from Schisandra chinensis Reverses P-Glycoprotein-Mediated Multidrug Resistance by Affecting Pgp-Substrate ComplexesPlanta Medica, 2007
- Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer AgentsJournal of Clinical Oncology, 2004